Strategic Financial Concepts LLC acquired a new position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 52,422 shares of the semiconductor company’s stock, valued at approximately $25,444,000. Synopsys makes up 0.8% of Strategic Financial Concepts LLC’s portfolio, making the stock its 13th biggest position.
A number of other hedge funds have also bought and sold shares of the stock. State Street Corp increased its stake in Synopsys by 1.7% during the 3rd quarter. State Street Corp now owns 6,948,473 shares of the semiconductor company’s stock valued at $3,518,637,000 after purchasing an additional 119,057 shares in the last quarter. Geode Capital Management LLC increased its stake in Synopsys by 1.9% during the 3rd quarter. Geode Capital Management LLC now owns 3,281,867 shares of the semiconductor company’s stock valued at $1,656,005,000 after purchasing an additional 61,799 shares in the last quarter. Edgewood Management LLC increased its stake in Synopsys by 18.9% during the 3rd quarter. Edgewood Management LLC now owns 3,069,848 shares of the semiconductor company’s stock valued at $1,554,540,000 after purchasing an additional 487,025 shares in the last quarter. Van ECK Associates Corp increased its stake in Synopsys by 26.5% during the 3rd quarter. Van ECK Associates Corp now owns 1,605,001 shares of the semiconductor company’s stock valued at $791,923,000 after purchasing an additional 335,993 shares in the last quarter. Finally, Parnassus Investments LLC acquired a new position in Synopsys during the 3rd quarter valued at approximately $633,469,000. Institutional investors and hedge funds own 85.47% of the company’s stock.
Synopsys Stock Performance
Shares of NASDAQ SNPS opened at $522.53 on Friday. The company’s fifty day moving average price is $510.78 and its 200 day moving average price is $518.06. Synopsys, Inc. has a 1 year low of $457.52 and a 1 year high of $629.38. The company has a market capitalization of $80.77 billion, a PE ratio of 35.99, a price-to-earnings-growth ratio of 3.49 and a beta of 1.12.
Wall Street Analyst Weigh In
Read Our Latest Stock Analysis on Synopsys
Insiders Place Their Bets
In other Synopsys news, CRO Richard S. Mahoney sold 20,838 shares of the company’s stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $506.01, for a total transaction of $10,544,236.38. Following the completion of the transaction, the executive now directly owns 1,460 shares in the company, valued at approximately $738,774.60. This represents a 93.45 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 0.66% of the stock is currently owned by company insiders.
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Recommended Stories
- Five stocks we like better than Synopsys
- Why is the Ex-Dividend Date Significant to Investors?
- Roblox’s Big Dip: A Chance to Get in on the Vaunted Gaming Stock?
- 3 Warren Buffett Stocks to Buy Now
- 3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
- Dividend Payout Ratio Calculator
- Is Chevron Stock Primed for Growth After Profit-Boosting News?
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.